BioNexus Gene Lab
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BGLC and other ETFs, options, and stocks.About BGLC
BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases.
CEOSu Leng Tan Lee
CEOSu Leng Tan Lee
Employees30
Employees30
HeadquartersKuala Lumpur, Wilayah Perseketuan (Federal Territory)
HeadquartersKuala Lumpur, Wilayah Perseketuan (Federal Territory)
Founded2017
Founded2017
Employees30
Employees30
BGLC Key Statistics
Market cap7.51M
Market cap7.51M
Price-Earnings ratio-3.33
Price-Earnings ratio-3.33
Dividend yield—
Dividend yield—
Average volume391.93K
Average volume391.93K
High today$4.30
High today$4.30
Low today$4.10
Low today$4.10
Open price$4.16
Open price$4.16
Volume14.06K
Volume14.06K
52 Week high$15.60
52 Week high$15.60
52 Week low$2.01
52 Week low$2.01
Stock Snapshot
As of today, BioNexus Gene Lab(BGLC) shares are valued at $4.26. The company's market cap stands at 7.51M, with a P/E ratio of -3.33.
On 2025-12-11, BioNexus Gene Lab(BGLC) stock traded between a low of $4.10 and a high of $4.30. Shares are currently priced at $4.26, which is +3.9% above the low and -0.8% below the high.
The BioNexus Gene Lab(BGLC)'s current trading volume is 14.06K, compared to an average daily volume of 391.93K.
In the last year, BioNexus Gene Lab(BGLC) shares hit a 52-week high of $15.60 and a 52-week low of $2.01.
In the last year, BioNexus Gene Lab(BGLC) shares hit a 52-week high of $15.60 and a 52-week low of $2.01.
People also own
Based on the portfolios of people who own BGLC. This list is generated using Robinhood data, and it’s not a recommendation.